2025-04-17 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Report

**0) Overview:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs and services.

**1) Performance Comparison:**

UNH's cumulative return (87.40%) significantly outperforms the S&P 500 (VOO) cumulative return (76.08%).  The difference is 11.3%, placing it at the 56.5th percentile of historical relative performance compared to the S&P 500 based on the provided min/max range (-43.3% to 53.4%).

**Alpha and Beta Analysis:**

The provided data shows varying Alpha and Beta values across different periods.  Alpha consistently remains positive, suggesting outperformance relative to the market benchmark, although the magnitude fluctuates significantly. Beta generally hovers around 1, indicating relatively similar volatility to the overall market, with some periods showing slightly higher or lower sensitivity.  Market capitalization (Cap) demonstrates consistent growth throughout the period.


| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 67.0% | 55.4% | 35.0% | 0.1 | 181.0 |
| 2016-2018  | 59.0% | 63.7% | 38.0% | 0.2 | 207.3 |
| 2017-2019  | 45.0% | 63.7% | 11.0% | 0.4 | 248.8 |
| 2018-2020  | -17.0% | 63.7% | -47.0% | 0.6 | 301.7 |
| 2019-2021  | 39.0% | 61.0% | -22.0% | 0.7 | 438.0 |
| 2020-2022  | 32.0% | 66.9% | 24.0% | 0.7 | 468.4 |
| 2021-2023  | 39.0% | 67.8% | 18.0% | 0.4 | 472.1 |
| 2022-2024  | -27.0% | 69.0% | -47.0% | 0.3 | 460.8 |
| 2023-2025  | 1.0% | 73.4% | -14.0% | 0.2 | 535.1 |


**2) Recent Price Movement:**

* **Closing Price:** $585.04
* **5-day Moving Average:** $589.91
* **20-day Moving Average:** $542.47
* **60-day Moving Average:** $517.60

The price is slightly below the 5-day moving average, suggesting a minor recent pullback.  However, it sits considerably above both the 20-day and 60-day moving averages, indicating a longer-term upward trend.  The daily change of $0.25 represents a relatively small price movement.


**3) Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.41 (Medium Risk)
* **RSI:** 75.90 (Overbought territory, suggesting potential for a near-term correction)
* **PPO:** 0.97 (Positive, indicating bullish momentum)
* **20-day Relative Strength Divergence:** +5.5 (Short-term upward trend)
* **Expected Return:** 10% (Long-term, 2+ years, outperformance vs. S&P 500)


**4) Recent Earnings Analysis:**

The provided earnings data shows some volatility.  While revenue consistently remains above $90B, EPS shows a significant drop in Q2 2024 (-$1.53) followed by substantial recovery in subsequent quarters.  Further investigation is needed to understand the reasons behind this volatility.

| 날짜       | EPS   | 매출       |
|------------|-------|------------|
| 2024-11-04 | 6.56  | 100.82 B$  |
| 2024-08-09 | 4.58  | 98.86 B$  |
| 2024-05-09 | -1.53 | 99.80 B$  |
| 2023-11-06 | 6.31  | 92.36 B$  |
| 2024-11-04 | 6.31  | 92.36 B$  | *(Duplicate entry likely a data error)*


**5) Financial Information:**

Revenue has remained relatively stable and high, while profit margins are consistently strong. ROE shows some volatility, including a negative value in Q1 2024, warranting further examination into the underlying causes.  Equity has generally increased throughout the period.

**Revenue and Profitability:**

| Quarter | Revenue     | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $100.81B   | 21.14%        |
| 2024-09-30 | $100.82B   | 22.84%        |
| 2024-06-30 | $98.86B    | 22.31%        |
| 2024-03-31 | $99.80B    | 23.05%        |
| 2023-12-31 | $94.43B    | 23.30%        |

**Capital and Profitability:**

| Quarter | Equity      | ROE     |
|---------|-------------|---------|
| 2024-12-31 | $92.66B    | 5.98%   |
| 2024-09-30 | $94.53B    | 6.41%   |
| 2024-06-30 | $89.36B    | 4.72%   |
| 2024-03-31 | $86.69B    | -1.63%  |
| 2023-12-31 | $88.76B    | 6.15%   |


**6) Summary:**

UNH shows strong historical performance, significantly outperforming the S&P 500.  While recent earnings show some volatility, overall revenue and profitability remain high.  Technical indicators suggest a potentially overbought condition in the short term, but the long-term outlook is positive, supported by a projected 10% outperformance of the S&P 500 over the next two years.  However, a deeper dive into the Q2 2024 EPS drop and the fluctuating ROE is necessary for a comprehensive risk assessment.  The provided data may be incomplete and requires further verification for a more robust conclusion.
